ClinicalTrials.gg
RecruitingNCT07718113Updated Nov 9, 2026

Exercise Snacking and Cardiometabolic Health

An interventional study of Exercise Snacking in Physical Inactivity, Sedentary Behavior and Cardiometabolic Health, sponsored by University of Wisconsin, River Falls. Recruiting at 1 site in United States. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by University of Wisconsin, River Falls · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Started Aug 2026; still recruiting 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Regular physical activity is associated with numerous health benefits, yet many young adults do not achieve recommended levels of physical activity. Exercise snacking, which involves performing brief bouts of physical activity throughout the day, may provide a practical alternative to traditional exercise programs by making physical activity easier to incorporate into daily routines.

This randomized controlled trial will evaluate whether a 12-week exercise snacking intervention improves physical activity levels, aerobic fitness, cardiometabolic health, and psychological well-being in insufficiently active young adults. Participants will be randomly assigned to either an exercise snacking intervention or a usual behavior control group. Assessments will be completed at baseline, after the 12-week intervention, and after an additional 12-week follow-up period to determine whether any changes are maintained after the intervention ends.

The study will measure physical activity using wearable activity monitors and assess aerobic fitness, body composition, blood pressure, blood lipids, glucose, exercise motivation, affective responses to exercise, and mental well-being. The findings will help determine whether exercise snacking is an effective and sustainable strategy for improving health in young adults and may inform future physical activity recommendations and interventions

Read the detailed description

Regular physical activity reduces the risk of cardiovascular disease, type 2 diabetes, obesity, and other chronic health conditions. Despite these well-established benefits, many young adults do not achieve recommended levels of physical activity. Commonly reported barriers include limited time, competing academic or work demands, and difficulty maintaining structured exercise programs.

Exercise snacking, defined as accumulating multiple brief bouts of moderate-to-vigorous physical activity throughout the day, has emerged as a potential strategy for increasing physical activity while minimizing many of the barriers associated with traditional exercise programs. Although short bouts of physical activity have demonstrated favorable acute physiological effects, relatively few randomized controlled trials have evaluated whether exercise snacking produces sustained improvements in objectively measured physical activity, physical fitness, cardiometabolic health, and psychological outcomes in free-living young adults.

The purpose of this study is to determine whether a 12-week exercise snacking intervention improves physical activity behavior, aerobic fitness, cardiometabolic health, exercise motivation, affective responses to physical activity, and psychological well-being compared with a usual behavior control group. Participants will be randomly assigned to either an exercise snacking intervention or a control condition. Following completion of the intervention, participants will be observed for an additional 12 weeks to evaluate the maintenance of behavioral and physiological changes after structured support is withdrawn.

The primary objectives are to determine whether exercise snacking increases objectively measured physical activity and improves aerobic fitness. Secondary objectives are to evaluate changes in body composition, blood pressure, fasting cardiometabolic biomarkers, exercise motivation, affective responses to exercise, and psychological well-being. Exploratory analyses will examine whether changes in motivation and affective responses are associated with long-term maintenance of physical activity during the follow-up period.

This study will contribute to the growing evidence regarding practical, scalable approaches for increasing physical activity among young adults and may help inform future lifestyle interventions and public health recommendations aimed at promoting long-term engagement in regular physical activity

02

Conditions studied

  • Physical Inactivity
  • Sedentary Behavior
  • Cardiometabolic Health

Keywords

  • exercise snacking
  • physical activity
  • aerobic fitness
  • behavioral intervention
  • exercise motivation
  • physical activity maintenance
  • randomized controlled trial
03

In context

Sedentary Behavior

1,273 studies on the registry are indexed under Sedentary Behavior; 300 are open to participants now.

This study's planned enrollment of 60 is close to the median of 60 across 1,076 interventional studies indexed under Sedentary Behavior.

Browse Sedentary Behavior studies →

Lead sponsor

University of Wisconsin, River Falls is the lead sponsor of 5 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18-60 years.
  • (BMI) ≥18.5 kg/m².
  • Insufficiently physically active, defined as generally not meeting current physical activity guidelines for moderate-to-vigorous physical activity.
  • Able to safely participate in moderate-to-vigorous physical activity as determined by study screening procedures, including completion of the Physical - Activity Readiness Questionnaire (PAR-Q+) and health history review.
  • Willing and able to provide written .
  • Willing to complete all study visits, wear activity monitors, and comply with study procedures.

Exclusion criteria

Exclusion Criteria:

  • Known cardiovascular, pulmonary, metabolic, neurological, orthopedic, or other medical conditions that would make participation in moderate-to-vigorous physical activity unsafe.
  • Resting heart rate >100 beats/minute at screening.
  • Resting blood pressure >160/100 mmHg at screening.
  • (ECG) abnormalities identified during screening that require medical evaluation.
  • Current participation in regular structured physical activity that meets or exceeds recommended physical activity guidelines.
  • Physical limitations or injuries that preclude safe participation in the intervention or fitness testing.
  • Moderate-to-severe psychological distress or other mental health concerns identified during screening that require referral or would make study participation inappropriate.
  • Pregnancy or any other condition judged by the investigators to make participation unsafe or interfere with completion of study procedures.
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

ECG (electrocardiogram)

A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Exercise Snacking

    Participants assigned to the exercise snacking group will complete a 12-week intervention consisting of multiple brief bouts (approximately 1-3 minutes each) of moderate-to-vigorous physical activity performed throughout the day. Participants will receive written instructions, examples of appropriate exercise snacks, and periodic check-ins to support adherence. The intervention is designed to increase daily physical activity by integrating short bouts of exercise into normal daily routines.

    Behavioral: Exercise Snacking

  • No intervention
    Usual Behavior Control

    Participants assigned to the control group will continue their usual daily activities for 12 weeks and will not receive instruction regarding exercise snacking or any structured physical activity program during the intervention period. They will complete the same outcome assessments as participants in the intervention group.

Interventions

  • BehavioralExercise Snacking

    Participants assigned to the intervention group will complete multiple brief bouts of moderate-to-vigorous physical activity throughout each day for 12 weeks. Each exercise snack will typically last approximately 1-3 minutes and may include activities such as stair climbing, brisk walking, repeated sit-to-stands, body-weight squats, or other moderate-to-vigorous activities that can be incorporated into daily routines. Participants will receive standardized written instructions, examples of exercise snacks, and periodic follow-up visits to monitor adherence and reinforce study procedures.

06

What researchers measure

Primary outcomes

  1. Moderate-to-Vigorous Physical Activity

    Average daily minutes of moderate-to-vigorous physical activity measured objectively using an accelerometer worn for seven consecutive days.

    Time frame: Baseline, Week 12, and Week 24

Secondary outcomes

  1. Body Fat Percentage

    Body composition measured using air displacement plethysmography (BodPod).

    Time frame: Baseline, Week 12, Week 24

  2. Aerobic Fitness

    Aerobic fitness assessed during a submaximal cycle ergometer exercise test with respiratory gas analysis using a metabolic measurement system.

    Time frame: Baseline, Week 12, and Week 24

  3. Fasting Blood Glucose

    Capillary fasting glucose measured using the Cholestech LDX analyzer.

    Time frame: Baseline, Week 12, Week 24

  4. Blood Lipid Profile

    Total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides measured from fasting capillary blood samples.

    Time frame: Baseline, Week 12, Week 24

  5. Exercise Motivation

    Exercise motivation will be assessed using the 24-item Behavioral Regulation in Exercise Questionnaire-3 (BREQ-3). The questionnaire produces six subscale scores: amotivation, external regulation, introjected regulation, identified regulation, integrated regulation, and intrinsic regulation. Each subscale is calculated as the mean of four items and ranges from 0 to 4. Higher scores indicate a greater degree of the corresponding type of exercise motivation; therefore, higher scores do not uniformly represent a better or worse outcome.

    Time frame: Baseline, Week 12, Week 24

  6. Psychological Well-Being

    Psychological well-being will be assessed using the World Health Organization-Five Well-Being Index (WHO-5). The five items are summed to produce a raw total score ranging from 0 to 25. Higher scores indicate better psychological well-being.

    Time frame: Baseline, Week 12, Week 24

  7. Depressive Symptoms

    Depressive symptoms will be assessed using the 9-item Patient Health Questionnaire (PHQ-9). Items are summed to produce a total score ranging from 0 to 27. Higher scores indicate more severe depressive symptoms and therefore a worse outcome.

    Time frame: Baseline, Week 12, Week 24

  8. Anxiety Symptoms

    Anxiety symptoms will be assessed using the 7-item Generalized Anxiety Disorder scale (GAD-7). Items are summed to produce a total score ranging from 0 to 21. Higher scores indicate more severe anxiety symptoms and therefore a worse outcome.

    Time frame: Baseline, Week 12, Week 24

  9. Perceived Stress

    Perceived stress will be assessed using the 10-item Perceived Stress Scale (PSS-10). Items are summed after reverse-scoring the positively stated items, producing a total score ranging from 0 to 40. Higher scores indicate greater perceived stress and therefore a worse outcome.

    Time frame: Baseline, Week 12, Week 24

Other outcomes

  1. Everyday Cognitive Failures

    Everyday cognitive failures will be assessed using the 25-item Cognitive Failures Questionnaire (CFQ). Items are summed to produce a total score ranging from 0 to 100. Higher scores indicate a greater frequency of everyday cognitive failures and therefore a worse outcome.

    Time frame: Baseline, Week 12, Week 24

  2. Exercise-Related Affective Valence

    Exercise-related affective valence will be assessed using the single-item Feeling Scale. Responses range from -5 ("very bad") to +5 ("very good"), with 0 representing "neutral." Higher scores indicate more positive affective valence and therefore a better outcome.

    Time frame: Baseline, Week 12, Week 24

  3. Academic engagement (UWES-S)

    Academic engagement will be assessed using the 9-item Utrecht Work Engagement Scale for Students (UWES-S-9), which measures vigor, dedication, and absorption in academic activities. Each item is scored from 0 ("never") to 6 ("always/every day"). Higher scores indicate greater academic engagement and therefore a better outcome.

    Time frame: Baseline, Week 12, Week 24

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Wan KW, Dai ZH, Wong PS, Huang WY, Lei EF, Little JP, Lin FC, Tam BT. Effects of Exercise Snacks on Cardiometabolic Health and Body Composition in Adults: A Systematic Review and Meta-Analysis. Scand J Med Sci Sports. 2025 Aug;35(8):e70114. doi: 10.1111/sms.70114. PubMed 40814152 ↗
  • Wang T, Laher I, Li S. Exercise snacks and physical fitness in sedentary populations. Sports Med Health Sci. 2024 Feb 27;7(1):1-7. doi: 10.1016/j.smhs.2024.02.006. eCollection 2025 Jan. PubMed 39649791 ↗
  • Yin M, Deng S, Chen Z, Zhang B, Zheng H, Bai M, Li H, Zhang X, Deng J, Liu Q, Little JP, Li Y. Exercise snacks are a time-efficient alternative to moderate-intensity continuous training for improving cardiorespiratory fitness but not maximal fat oxidation in inactive adults: a randomized controlled trial. Appl Physiol Nutr Metab. 2024 Jul 1;49(7):920-932. doi: 10.1139/apnm-2023-0593. Epub 2024 Apr 3. PubMed 38569204 ↗
  • Jenkins EM, Nairn LN, Skelly LE, Little JP, Gibala MJ. Do stair climbing exercise "snacks" improve cardiorespiratory fitness? Appl Physiol Nutr Metab. 2019 Jun;44(6):681-684. doi: 10.1139/apnm-2018-0675. Epub 2019 Jan 16. PubMed 30649897 ↗

Individual participant data

Plan to share: Yes — De-identified individual participant data underlying the results reported in publications arising from this study may be shared with qualified researchers upon reasonable request to the Principal Investigator. Data will become available beginning six months after publication of the primary study results and remain available for up to five years. Requests should include a brief research proposal and analysis plan and will be evaluated based on scientific merit and the proposed use of the data. When applicable, a data use agreement will be required before data are shared. The study protocol, statistical analysis plan, data dictionary, and analytic code (if applicable) may also be made available. All data sharing will comply with institutional policies and applicable regulations to protect participant confidentiality.

Supporting information: Study protocol, Statistical analysis plan, Analytic code

Time frame: De-identified individual participant data and supporting documentation will be available beginning six months after publication of the primary study results and will remain available for five years thereafter.

Access criteria: De-identified individual participant data, the study protocol, statistical analysis plan, and analytic code may be made available to qualified researchers upon reasonable request to the Principal Investigator. Requests should include a brief research proposal and analysis plan and will be evaluated based on scientific merit, investigator qualifications, and the proposed use of the data. When applicable, a data use agreement will be required prior to data sharing. All shared data will be de-identified and released in accordance with institutional policies and applicable regulations to protect participant confidentiality.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2026 (actual). Primary completion is estimated for Dec 2027, 16 months after the start.

Of 733 non-industry interventional studies with no phase under Sedentary Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 31. This study's planned 16 months is above that.

Counting every sponsor, half of 741 studies reached it within 14 months; a quarter within 6 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 16, 2026
First posted
Jul 21, 2026
StartActual
Aug 1, 2026
Primary completionEst.
Dec 31, 2027
CompletionEst.
Dec 31, 2027
Last update
Nov 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date and date precision
1 update, last Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    Minor edits only
    + 2 other changes: verification date and date precision

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07718113
Lead sponsor
University of Wisconsin, River Falls
Responsible party
Gregory Ruegsegger (Professor, University of Wisconsin, River Falls) — Principal investigator
First posted
Jul 21, 2026
Start date
Aug 1, 2026
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Nov 9, 2026

Study contacts

Gregory Ruegsegger, PhD
Contact
gregory.ruegsegger@uwrf.edu
715-425-4945
Ricky Lopez, MS
Contact
ricky.lopez@uwrf.edu
715-425-4138
Gregory Ruegsegger, PhD
principal investigator · University of Wisconsin, River Falls

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion